29,075 results on '"interferon-alpha"'
Search Results
52. Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
53. Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.
54. Influence of alpha-glutamil-tryptophan on the background and induced activity of factors of adaptive immunity for prevention
55. PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma
56. Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B (EPCP)
57. High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
58. Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
59. Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
60. Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma
61. Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
62. Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
63. Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma (EURAMOS-1)
64. Pegasys® in Patients With Myeloproliferative Diseases
65. Treatment of HPV Infection in Perimenopausal and Postmenopausal Women
66. To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs. (IFNA2/ISGs)
67. The Clinical Cure Project of Chronic Hepatitis B in China
68. Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a (D-LIVR)
69. Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma (SICOG 0109)
70. Mindin蛋白在经聚乙二醇干扰素 α-2b 治疗的慢性乙型肝炎中的 动态变化及意义.
71. Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy
72. ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission (ENDURE-CML-IX)
73. Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT
74. Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients
75. Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2) (LOWR-2)
76. Replicor Compassionate Access Program (RCAP)
77. Telaprevir in Genotype 3 HCV (TIG3)
78. Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
79. Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α.
80. Lonafarnib With and Without Ritonavir in HDV (LOWR-1) (LOWR-1)
81. A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B
82. Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma
83. Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.
84. IFNα-blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health
85. BRD9 regulates interferon-stimulated genes during macrophage activation via cooperation with BET protein BRD4
86. A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir
87. Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients
88. Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19) (IN2COVID)
89. Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg (RUXOPeg)
90. A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms (DALIAH)
91. Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B
92. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
93. Vitamin C Enhances Antiviral Functions of Lung Epithelial Cells.
94. Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
95. Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC
96. Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE) (WRITE)
97. Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
98. Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma
99. Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
100. Peginterferon Alpha-2b Therapy in Chronic Hepatitis Patients With Normal ALT Level and Low Viremia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.